Kodak shares fell sharply on Monday as a U.S. government established financial institution suspended a loan, AFP reported. The loan was intended to support the former film giant to start a new pharmaceutical business. < p > < p > on July 28, DFC announced a US $765 million loan to Kodak. But after the controversy, the agency said on Friday it would stop further action. The loan is part of the trump administration’s plan to improve U.S. pharmaceutical capacity in the wake of the new outbreak. Kodak’s shares fell 28.3% to $10.67 in afternoon trading, according to the report. According to the Wall Street Journal, the securities and Exchange Commission is investigating Kodak’s disclosure of loan related information and will also investigate the company’s granting of executive stock options. < / P > < p > the day before DFC announced its loan statement, Kodak’s share price soared by 500% on July 28. < / P > < p > DFC tweeted on Friday: “on July 28, we signed a letter of intent with Eastman Kodak. The recent accusations of wrongdoing have aroused our serious concern. We will not take further action unless these charges are proved innocent. ” According to the report, DFC’s loan to Kodak will be the first loan since President trump signed the defense production act in May this year, which aims to encourage the production of pharmaceutical materials needed to fight the new coronavirus in the United States. Senior members of the US House of representatives also questioned the loan. Some lawmakers, including Maxine Waters, chairman of the financial services committee, and Eliot Engel, chairman of the Foreign Affairs Committee, wrote to DFC, pointing out that Kodak’s previous attempts in the pharmaceutical sector were “not successful.”.